NUAgo Therapeutics Revenue

Biotechnology Research • Chicago, Illinois, United States • 1-10 Employees

NUAgo Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at NUAgo Therapeutics

Robert Schickel

Chief Executive Officer, Co-Founder

Company overview

Headquarters	Chicago, Illinois, United States
Website	nuagotherapeutics.com
NAICS	541714
Founded	2020
Employees	1-10

NUAgo Therapeutics Email Formats

NUAgo Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@nuagotherapeutics.com), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@nuagotherapeutics.com	50%
{first name}{last name}	johndoe@nuagotherapeutics.com	50%

About NUAgo Therapeutics

NUAgo Therapeutics is redefining the precision approach in cancer therapeutics. We are a pre-clinical stage company developing single-construct short RNAs that target dozens of critical cancer essential genes in systemic delivery platform that kill tumors specifically without observed toxicity in normal tissues. No longer bound to the treatment restrictions imposed due to patient and tumor heterogeneity, NUAgo's short RNAs offer the promise shift to potentially shift cancer therapy toward a chronic-like condition with periods of complete response or tumor elimination. Reach out to us if you would like to learn more.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

NUAgo Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

NUAgo Therapeutics has never raised funding before.

NUAgo Therapeutics Tech Stack

Discover the technologies and tools that power NUAgo Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Vue.js

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

Netlify

CDN

Microsoft 365

Frequently asked questions

NUAgo Therapeutics is located in Chicago, Illinois, US.

NUAgo Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

NUAgo Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NUAgo Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

NUAgo Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at NUAgo Therapeutics

Robert Schickel

Chief Executive Officer, Co-Founder

4.8

40,000 users